Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.”

Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.”

“Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.”

The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitiser,” he said.

The above is taken from an interview Maria Zeee conducted with Dr. William Makis in a recent episode of Vigilant News Network’s ‘Media Blackout’. At the time of writing, the video was still streaming live so we were not able to embed the video here.  You can watch the Media Blackout episode HERE.  The section with Dr. Willaim Makis begins at around 4 minutes after the start.  You can also watch the relevant clip from the video on Rumble on Twitter (now X) HERE.

Related: Mel Gibson Drops Two Medical Bombshells on the Joe Rogan Podcast, Vigilant News Network, 9 January 2025

The following is the episode of the Joe Rogan Experience referenced by Maria Zeee where Gibson dropped his bombshells.  We have embedded the Rogan interview to begin at the timestamp in which Gibson said: “I have three friends. All three of them had stage four cancer. All three of them don’t have cancer right now at all … [they took] Ivermectin [and] Fenbendazole.”

Joe Rogan Experience #2254 – Mel Gibson, 9 January 2025 (141 mins)

The Chief Nerd tweeted a clip of Gibson’s remarks above form the Joe Rogan Experience, to which Canadian radiologist, oncologist and cancer researcher Dr. Willilam Makis responded confirming that he had treated one of Gibson’s friends with Ivermectin and Fenbendazole.

American biologist, chemist, biochemist, neuroscientist and medical doctor Andrew Zywiec also responded to The Chief Nerd’s tweet:

Twitter user said he didn’t believe Dr. Zywiec and asked for peer-reviewed studies to support his claims.  Dr. Zywiec obliged and provided a few studies for his challenger to consider.  “Here is enough literature on bendazole drugs and Ivermectin for you to review.  Don’t message me for at least several days, otherwise, I will know you didn’t read or review any of it,” he said attaching the links below:

  1. Ghasemi F, Black M, Vizeacoumar F, Pinto N, Ruicci KM, Le CCSH, Lowerison MR, Leong HS, Yoo J, Fung K, MacNeil D, Palma DA, Winquist E, Mymryk JS, Boutros PC, Datti A, Barrett JW, Nichols AC. Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer. Oncotarget. 2017 Apr 20;8(42):71512-71519. doi: 10.18632/oncotarget.17292. PMID: 29069723; PMCID: PMC5641066.
  2. Fatima, I., Ahmad, R., Barman, S. et al. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. Br J Cancer 130, 1046–1058 (2024). https://doi.org/10.1038/s41416-023-02570-x
  3. Kim U, Shin C, Kim C, Ryu B, Kim J, Bang J and Park J: Albendazole exerts antiproliferative effects on prostate cancer cells by inducing reactive oxygen species generation. Oncol Lett 21: 395, 2021.
  4. L.S.E.P.W. Castro, M.R. Kviecinski, F. Ourique, E.B. Parisotto, V.M.A.S. Grinevicius, J.F.G. Correia, D. Wilhelm Filho, R.C. Pedrosa, Albendazole as a promising molecule for tumor control, Redox Biology, Volume 10, 2016, Pages 90-99, ISSN 2213-2317, https://doi.org/10.1016/j.redox.2016.09.013.
  5. S. Javdan, H. Nayeri, G. Vaseghi: Cytotoxic Effect of Albendazole on the Breast Cancer and Melanoma Cell Lines, Zahedan Journal of Research in Medical Sciences, 2018, https://doi.org/10.5812/zjrms.9100
  6. Zhou, Shican  and Wu, Hang  and Ning, Wenjuan  and Wu, Xiao  and Xu, Xiaoxiao  and Ma, Yuanqiao  and Li, Xingwang  and Hu, Junhong  and Wang, Chenyu  and Wang, Junpeng: Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth, Frontiers in Pharmacology, Volume 12, 2021, DOI: 10.3389/fphar.2021.717529.
  7. Phase II trial studies: Ivermectin and Pembrolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, US National Cancer Institute

To which we add another study:

Dr. Makis publishes articles on a Substack page titled ‘Covid Intel’.   His articles are behind a paywall. However, at the beginning of an article last year, he published a table summarising dosages and reports of success stories using Ivermectin to treat cancer.

Source:  https://expose-news.com/2025/01/13/ivermectin-and-fenbendazole-treats-cancer/

Bitchute: https://www.bitchut,e.com/channel/YBM3rvf5ydDM/

Gab: https://gab.com/hopegirl

Telegram: https://t.me/Hopegirl587

EMF Protection Products: www.ftwproject.com

QEG Clean Energy Academy: www.cleanenergyacademy.com

Forbidden Tech Book: www.forbiddentech.website